131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study

被引:0
作者
Kuan-Yin Ko
Chia-Hung Kao
Cheng-Li Lin
Wen-Sheng Huang
Ruoh-Fang Yen
机构
[1] National Taiwan University Hospital,Department of Nuclear Medicine
[2] China Medical University,Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine
[3] China Medical University Hospital,Department of Nuclear Medicine and PET Center
[4] China Medical University Hospital,Management Office for Health Data
[5] China Medical University,College of Medicine
[6] Changhua Christian Hospital,Department of Nuclear Medicine
[7] National Taiwan University Hospital,Department of Nuclear Medicine
[8] National Taiwan University College of Medicine,Department of Radiology
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2015年 / 42卷
关键词
Radioiodine; Thyroid cancer; Salivary gland; Lacrimal gland; Second primary malignancy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1172 / 1178
页数:6
相关论文
共 41 条
  • [41] Risk of thyroid cancer associated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A population-based cohort study
    Bea, Sungho
    Son, Heejun
    Bae, Jae Hyun
    Cho, Sun Wook
    Shin, Ju-Young
    Cho, Young Min
    DIABETES OBESITY & METABOLISM, 2024, 26 (01) : 108 - 117